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Aerobic glycolysis (AG; i.e., nonoxidative meta-
bolism of glucose despite the presence of abundant
oxygen) accounts for 10%–12% of glucose used by
the adult human brain. AG varies regionally in the
resting state. Brain AG may support synaptic growth
and remodeling; however, data supporting this
hypothesis are sparse. Here, we report on investi-
gations on the role of AG in the human brain. Meta-
analysis of prior brain glucose and oxygen meta-
bolism studies demonstrates that AG increases
during childhood, precisely when synaptic growth
rates are highest. In resting adult humans, AG corre-
lates with the persistence of gene expression typical
of infancy (transcriptional neoteny). In brain regions
with the highest AG, we find increased gene expres-
sion related to synapse formation and growth. In
contrast, regions high in oxidative glucose meta-
bolism express genes related to mitochondria and
synaptic transmission. Our results suggest that brain
AG supports developmental processes, particularly
those required for synapse formation and growth.
INTRODUCTION
The adult human brain, though a mere 2%–3% of total body
weight, consumes nearly 20% of the human body’s basal meta-
bolic rate (Clarke and Sokoloff, 1999). Building a human brain is
even more expensive. Conservative estimates suggest that an
infant’s brain consumes more than 40% of the body’s basal
metabolic rate (Durnin, 1981). This figure is particularly impres-
sive, given that the basal metabolic rate per square meter of
surface area is larger in children than it is in adults (Durnin, 1981).
Glucose normally supplies the vast majority of calories
consumed by the adult brain. Most of this glucose is oxidized
in order to supply the large amounts of ATP required to maintain
membrane ion gradients and other cellular processes related to
synaptic transmission (Attwell and Laughlin, 2001; Lennie, 2003;
Raichle and Mintun, 2006; Sibson et al., 1997, 1998). Yet, quan-
titative measurements of brain metabolism reveal that approxi-
mately 10%–12% of the total glucose consumed by a normal
adult brain (CMRglc) is in excess of oxygen consumptionC(CMRO2) (Boyle et al., 1994; Madsen et al., 1995; Powers
et al., 2007; Raichle et al., 1970; Vaishnavi et al., 2010). The
metabolic origin of this nonoxidative metabolism of glucose is
debated. In normal, awake, resting adult humans, lactate efflux
most likely accounts for20% of this excess glucose consump-
tion (Madsen et al., 1995; Raichle et al., 1970), though estimates
vary (Dalsgaard et al., 2004). We refer to this total excess brain
glucose consumption as ‘‘aerobic glycolysis’’ (AG) on the basis
of a similar, well-described phenomenon found in cancer cells
(Lunt and Vander Heiden, 2011; Vaishnavi et al., 2010).
In the resting adult human brain, AG varies regionally: nearly
25% of resting glucose consumption is nonoxidative in the
medial prefrontal gyrus, whereas AG comprises only 2% of
glucose consumption in the cerebellum (Figure 1) (Vaishnavi
et al., 2010). A recent meta-analysis of studies on human brain
oxygen and glucose consumption identified a similar regional
variance of AG (Hyder et al., 2013). AG correlates with centrality
as defined by large-scale, structural, and resting state functional
connectivity studies of the human brain (Bullmore and Sporns,
2012; Vaishnavi et al., 2010). Furthermore, AG identifies regions
most vulnerable to amyloid-beta deposition in Alzheimer’s dis-
ease (Vlassenko et al., 2010). Uncoupling of glucose metabolism
from oxygen consumption is characteristic of the brain’s
response to imposed tasks (‘‘activation’’) (Fox et al., 1988). Curi-
ously, AG persists for at least 40 min after cognitive demanding
task performance despite the return of blood flow and lactate
production to control levels (Fox et al., 1988; Madsen et al.,
1995).
AG is a prominent feature of cancer cell metabolism; its main
role is thought to be the support of biosynthetic pathways
required for cellular proliferation (Locasale and Cantley, 2011;
Lunt and Vander Heiden, 2011). Might AG serve a similar role
in the brain (i.e., biosynthetic support of synapse and neurite
formation)? To explore this hypothesis, we performed a series
of analyses starting with a literature-basedmeta-analysis of prior
investigations of glucose and oxygen consumption across the
lifespan.
We also compared in vivo regional adult brain AG measure-
ments, previously obtained by our laboratory with (positron
emission tomography) PET imaging, to postmortem gene
expression data obtained in 16 different brain regions in over
50 brains acquired across the human lifespan (BrainSpan Study
[BSS], http://brainspan.org; Kang et al., 2011). To improve the
external validity of our results, we used a second, independent
source of adult human brain gene expression (Allen Human Brain
Atlas [AHBA], http://brain-map.org; Hawrylycz et al., 2012) toell Metabolism 19, 49–57, January 7, 2014 ª2014 Elsevier Inc. 49
Figure 1. Human Brain AG Varies Regionally in Healthy Adults
AGwasmeasured as previously described (Vaishnavi et al., 2010) in 33 normal
young adults. AG, expressed as the glycolytic index, is illustrated here on the
lateral andmedial brain surface. Computed AG has been geodesically (parallel
to the cortical surface) smoothed. The highest levels of AG occur in the medial
frontal gyrus, precuneus, and posterior cingulate cortex, as previously
reported.
Figure 2. Brain Metabolism across the Lifespan
(A)Whole-brain or cerebral total glucose consumption rates (blue circles) and a
fit obtained with loessR (blue line, see the Experimental Procedures for details)
demonstrate an approximate doubling of CMRglc during early childhood. The
expected glucose consumption based on measured oxygen consumption
rates is also plotted (red circles and line). This also increases during early
childhood, though it did so less than the measured changes in CMRglc,
suggesting that approximately 30% of the CMRglc during childhood is in
excess of oxygen consumption (i.e., aerobic glycolysis).
(B) CMRglc (blue), CMRO2 (red), and CBF (orange) were plotted across the
lifespan as normalized proportions of average adult values. This analysis
shows an approximate 2-fold rise in CMRglc and 1.5-fold rise in CMRO2 during
early childhood. Interestingly, CBF also increases 2-fold during early child-
hood, matching the changes in CMRglc, but it then appears to more closely
follow changes in CMRO2 during adulthood. The raw and normalized data are
shown in Table S1.
As discussed in the Results, data were gathered from 15 different studies
dating back to 1953. See also Table S1.
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Human Brain Neoteny and Aerobic Glycolysisidentify genes that are most highly expressed in brain regions
with high AG. Finally, we contrasted the relationship between
gene expression and AG to gene expression relationships with
other metabolic parameters, such as CMRglc. The observed
patterns of gene expression support our hypothesis that brain
AG supports the biosynthetic requirements of synaptic growth
and remodeling.
RESULTS
Meta-Analysis of Prior Studies of Brain Glucose and
Oxygen Consumption
We present a meta-analysis of prior studies of whole-brain
glucose and oxygen consumption across the human lifespan.
We identified several studies of human subjects dating back to
1953 that obtained quantitative measurements of whole-brain
or cerebral glucose and oxygen consumption during various
stages of life, including premature neonates, growing normal
children, young adults, and the elderly (Altman et al., 1993; Burns
and Tyrrell, 1992; Chugani et al., 1987; Frewen et al., 1991;
Himwich et al., 1959; Kennedy and Sokoloff, 1957; Kinnala
et al., 1996; Kuhl et al., 1982; Leenders et al., 1990; Pantano
et al., 1984; Perlmutter et al., 1987; Petit-Taboue´ et al., 1998;50 Cell Metabolism 19, 49–57, January 7, 2014 ª2014 Elsevier Inc.Scheinberg et al., 1953; Takahashi et al., 1999; Yoxall and Wein-
dling, 1998). We combined the reported values of whole-brain or
cerebral glucose and oxygen consumption from these studies in
order to create a summary representation of these metabolic
variables as a function of age across the human lifespan (Table
S1 available online). Glucose consumption is plotted in standard
units across the human lifespan, and, for comparison, oxygen
consumption is plotted in terms of the amount of glucose
consumption to be expected if all the glucose consumed were
ultimately metabolized via oxidative phosphorylation (Figure 2A).
Figure 3. Transcriptional Neoteny Regionally Correlates with
Aerobic Glycolysis
We assessed the transcriptional neoteny in each of 15 regions from the BSS in
comparison to the cerebellum. A genewas defined as neotenous in a particular
region if its expression demonstrated delayed, prolonged, or potentiated
expression in comparison to its expression in the cerebellum. Thus, by defi-
nition, there are zero neotenous genes in the cerebellum (CBC) in comparison
to itself. The number of neotenous genes in each region (that is, the regional
neoteny index) increases in relation to aerobic glycolysis (r = 0.77, Pearson
correlation, p = 0.0008, 95% CI, 0.43–0.92). The median age shift across all
genes for each region in comparison to the cerebellum also correlates with
aerobic glycolysis (r = 0.71, Pearson correlation, p = 0.003, 95%CI, 0.31–0.90).
Regions are named according to the BSS (Kang et al., 2011): CBC, cerebellum;
MD, thalamus; AMY, amygdala; HIP, hippocampus; ITC, inferior temporal
cortex; STR, striatum; V1C, primary visual cortex; STC, superior temporal
cortex; A1C, auditory cortex; IPC, inferior parietal cortex; M1C, primary motor
cortex; S1C, primary somatosensory cortex; MFC, medial frontal cortex; OFC,
orbital frontal cortex; DFC, dorsal frontal cortex; and VFC, ventral frontal
cortex.
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Human Brain Neoteny and Aerobic GlycolysisDuring much of adult life, brain glucose consumption is only
slightly greater than that expected on the basis of brain oxygen
consumption, andwhole-brain AG appears to virtually disappear
in the elderly (Figure 2A). However, AG increases dramatically
during childhood and accounts for approximately one-third of
total glucose consumption at its peak age of 5 years, when
total glucose consumption exceeds adult levels by a factor of
two. To compare glucose and oxygen consumption to relative
changes in cerebral blood flow, we replotted the data in terms
of a ratio relative to adult values (Figure 2B). Interestingly, resting
cerebral blood flow tracks glucose utilization during childhood
and then tracks oxygen consumption during adulthood.
We averaged reported metabolic data across the lifespan and
calculated an oxygen-glucose index (OGI) for each develop-
mental stage. In these calculations, 6 mol of oxygen were
consumed for each mol of glucose oxidized to carbon dioxide
and water, and this ratio is referred to as the OGI. An OGI < 6
indicates AG, whereas anOGI > 6 indicates that the brain is using
an alternative fuel for energy; e.g., ketone bodies (Dastur, 1985).
We found that OGI is5 during the fetal period, decreases to <4
during early childhood, progressively rises to 5.67 in young and
middle-aged adults, and ultimately exceeds 6 in older adults
(Table S1). The decrease in AG from young adulthood to aCmean age in the 70s has been described previously (Dastur,
1985); in that study, the whole-brain OGI was 4.7 in normal
subjects with mean age 21 in comparison to an OGI of 5.9 in
older subjects with mean age of 71. Thus, the available data
demonstrate that brain AG peaks (OGI is at a minimum) precisely
when synaptic development peaks in the human brain; i.e.,
during early childhood.
Comparison of Regional AG to Transcriptional Neoteny
We reasoned that, if AG is increased in the developing brain, then
regionally high AG in the adult human brainmay reflect persistent
developmental processes. The persistence of developmental
features and processes into adulthood is referred to as
‘‘neoteny’’ (Bufill et al., 2011). A classic example is that adult
human faces tend to better resemble juvenile chimpanzee faces
than their adult counterparts. Neoteny traditionally has been
assessed in terms of cross-species comparisons (Gould,
2000). More recently, the concept has been broadened to
encompass within-species delayed maturation of specific
features (Petanjek et al., 2011).
To measure regional transcriptional neoteny in the human
brain, we used the BSS, a publicly available, whole-genome
gene expression microarray data set representing 16 different
brain regions over 50 human brains across the fetal-adulthood
lifespan (Kang et al., 2011). We assessed transcriptional neoteny
using a measure previously constructed to demonstrate neoteny
in the dorsolateral prefrontal cortex and superior frontal gyrus in
humans in comparison to chimpanzees and macaques (Somel
et al., 2009); incidentally, both regions exhibit high AG in normal
human adults (Vaishnavi et al., 2010). Specifically, we defined
the regional neoteny index as the number of neotenous genes
within each of the 16 regions assessed in the BSS relative to
the cerebellum; the cerebellumwas chosen as the ‘‘reference re-
gion’’ in this analysis because of its lowest aerobic glycolysis
relative to any other of the 16 regions.
To investigate the relationship between this regional neoteny
index and AG, we assigned each of the 16 regions an AG value
with regional PET imaging data previously obtained by our labo-
ratory in resting, healthy young adults (Vaishnavi et al., 2010). For
example, AG in the cerebellum, as measured with the glycolytic
index, was 143, whereas AG in the dorsolateral frontal cortex
(including Brodmann areas 9 and 46) was 127 (Vaishnavi et al.,
2010). Across these 16 regions, the neoteny index was
significantly correlated with AG (Pearson correlation = 0.77,
r2 = 0.59, p = 0.0008, 95% confidence interval [CI], r = 0.43–
0.92; Figure 3). A related measure of regional transcriptional
neoteny—the median ‘‘age shift’’ (Somel et al., 2009)—revealed
very similar results (Pearson correlation = 0.71, r2 = 0.5, p =
0.003, 95% CI, r = 0.31–0.90). Thus, gene expression data
strongly suggest that the regional dependence of AG in the adult
brain reflects a persistent developmental character, specifically,
neoteny.
AG Is Related to Spatially Specific Gene Expression
Next, we sought to identify specific genes whose expression
spatially correlates with AG in the adult brain. To maximize the
integrity of this analysis, we limited the comparison to five age-
matched BSS brains, each including one or two samples from
16 different regions. Furthermore, we included another regionalell Metabolism 19, 49–57, January 7, 2014 ª2014 Elsevier Inc. 51
Table 1. Gene Ontology Results for the Top 116 Genes
Correlating with AG
Functional Term Group Enrichment Score
Neuronal projections, dendrites, axons 2.66
Ion channels 2.25
Synapses, dendritic spines 1.57
Regulation of secretion and transport 1.40
Neuronal development, axonogenesis 1.18
Cytoplasmic vesicles 1.18
Neuronal differentiation, neuron
projection development
1.11
Regulation of cell development and
differentiation
1.04
The top 116 genes (Table S2) associated with adult human brain AGwere
identified as those that consistently occurred among the top 1,000 out of
17,205 genes whose expressions correlate with AG in the AHBA and five
matched BSS brains. DAVID Bioinformatics Resources (version 6.7) was
used to functionally characterize these genes (Huang da et al., 2009). Top
functional terms with a group enrichment score > 1.0 are listed and, in
general, include axons, dendrites, and the regulation of their develop-
ment (see Table S3 for the full list). Similar results are obtained with other
gene ontology tools, including GeneMANIA and userListEnrichment
(Table S4) (Miller et al., 2011; Warde-Farley et al., 2010). A permutation
analysis showed that the discovery of the 116 genes is statistically
unlikely by chance alone (Figure S1).
See also Figure S1 and Tables S2–S4.
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Human Brain Neoteny and Aerobic Glycolysisbrain gene expression data set from the AHBA, which was
acquired independently from the BSS and included whole-
genome microarray measurements from approximately 900
different brain regions.
For each of the 16 regions sampled in the five BSS brains, we
assigned an AG value in the same manner as described above.
We assigned an AG value to each of the 900 brain regions
sampled in the AHBA brain by measuring the glycolytic index
in our PET data at the Montreal Neurological Institute (MNI) coor-
dinate provided for each of the AHBA regions. Then, AG was
correlated to the expression of each gene, and the top 1,000 cor-
relations were identified for each of the six brains (five BSS and
one AHBA brains, cumulative false discovery rate [FDR] for top
1,000 correlations across all six brains = 0.045). Finally, to maxi-
mize the external validity of this analysis, we isolated genes
consistently found in the top 1,000 for all six brains (given cumu-
lative FDR < 0.05, the chance that the same false positive gene
would occur in all six brains is exceedingly low).
The number of genes satisfying these stringent criteria was
116 (Table S2, see also Table 1). To further assess the statistical
significance of this finding, we randomly shuffled aerobic glycol-
ysis values among the brain regions and repeated the analysis.
Only 2% of the random permutations reproduced an equal or
greater number of consistent genes (Figure S1). Thus, aerobic
glycolysis in the adult human brain is significantly associated
with a consistent pattern of gene expression as identified by
these 116 genes. In contrast, performing the same analysis to
identify genes associated with CMRglc revealed only 38 genes.
Gene EPHB6 (ephrin type B receptor 6) emerged as the gene
with the strongest association with aerobic glycolysis. This gene
was among the top 40 in all six brains, which is extremely unlikely52 Cell Metabolism 19, 49–57, January 7, 2014 ª2014 Elsevier Inc.by chance alone (p < 108, Bonferroni corrected). Ephrins and
ephrin receptors are known to support a variety of development
and remodeling functions, including the regulation of axon
guidance and development of dendritic filopodia (Klein, 2009).
Other top 116 associations with aerobic glycolysis included
potassium ion channels, genes implicated in synaptic transmis-
sion and plasticity, neuropeptides and neuropeptide receptors,
and NRGN (neurogranin), a gene implicated in schizophrenia
(Stefansson et al., 2009).
We used DAVID Bioinformatics Resources (version 6.7) to
characterize the functional relevance of these 116 genes (Huang
da et al., 2009). These AG-related genes are enriched for genes
associated with axons, dendrites, and their development (Tables
1 and S3). In contrast, the 38 genes associated with CMRglc are
only enriched for genes related to the regulation of transcription
and other DNA binding activities (group enrichment score =
1.36). For the 116 AG-related genes, an independent gene
ontology tool, GeneMANIA (http://genemania.org), confirmed
that these genes are associated with neuronal projections and
axonal and dendritic development (Table S4A) (Warde-Farley
et al., 2010). Using userListEnrichment, a program in the
weighted gene coexpression network analysis (WGCNA) pack-
age (Langfelder and Horvath, 2008) that identifies gene list
enrichment in brain-specific data sets, we found that the 116
AG-related genes are also enriched for neuron-specific markers,
genes downregulated in Alzheimer’s disease and aging, and
genes associated with autism (p < 0.05, Bonferroni corrected;
Table S4B). There was also gene enrichment for proteins found
in the human postsynaptic density but no significant enrichment
of genes related to glycolysis or genes regulated by agonal
stress (Langfelder and Horvath, 2008; Li et al., 2007).
Next, having identified 116 genes that are consistently ex-
pressed in glycolytic regions of adult human brains, we explored
their temporal expression by measuring their average gene
expression in the BSS across the human lifespan. We found
that the 116 glycolytic genes collectively exhibit a unique expres-
sion pattern across the lifespan (Figure 4A) that strikingly varies
across the brain. During the early fetal period, there is little differ-
ential regional expression. Postnatally, cerebellar expression
(the area in the adult brain with the lowest level of AG; see Fig-
ure 1) falls while cortical expression continues to rise. Within
the cortex, the rise during postnatal development and subse-
quent persistence during adulthood is highest within association
areas that, as a whole, include the brain regions with the highest
AG (Figure 4B).
It is noteworthy that genes coding for enzymes directly asso-
ciated with glycolysis were not included among the 116 genes
consistently correlating with aerobic glycolysis. This is not sur-
prising given that glycolysis occurs equally in regions with high
oxidative metabolism. Using a less stringent statistical test, we
found only two glycolytic isoenzymes that significantly corre-
lated with aerobic glycolysis in all six brains (PDK3, pyruvate
dehydrogenase kinase 3, and PPM2C, pyruvate dehydrogenase
phosphatase catalytic subunit 1 [now known as PDP1]; p < 0.05,
Holm-Bonferroni corrected across glycolysis isoenzymes). Both
PDK3 and PPM2C directly regulate pyruvate metabolism in that
PDK3 potently inhibits pyruvate dehydrogenase activity, and
PPM2C contributes to pyruvate dehydrogenase activation.
Thus, the two genes act as ‘‘switches’’ that determines whether
Figure 4. Expression of the 116 Genes Related to Brain AG Rises and Persists in the Cortex, Particularly Neocortical Areas, during the
Human Lifespan
(A) The expression of the 116 genes most consistently correlating with aerobic glycolysis in adults is plotted across the lifespan in the BSS. Lines are smoothed
and normalized group averages. Shaded regions represent 95% CIs of the mean. The first few months of postconception fetal life are associated with parallel
increases in expression across the brain. However, a dramatic divergence occurs at midgestation with expression failing in the cerebellum (red line), stabilizing in
the diencephalon (orange), and continuing to increase in the striatum (green) and even more so in the cerebral cortex (blue).
(B) Within the postnatal cerebral cortex, the 116 genes are most highly expressed in neocortex, particularly in association areas (dark blue line), slightly (but not
significantly) less so in primary sensorimotor regions (teal line), and significantly less so in the hippocampus and amygdala (sky blue). The overall relationship
among these regions suggests that these genes are more likely to persist at higher levels during adulthood in regions associated with high aerobic glycolysis.
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Human Brain Neoteny and Aerobic Glycolysisthe end product of glycolysis is directed toward oxidative phos-
phorylation or alternative pathways. Indeed, the upregulation of
PDK3 acts as a switch for aerobic glycolysis in certain cancer
cell lines (Lu et al., 2008).
Comparison of AG-Related Brain Gene Expression to
CMRglc and Other Metabolic Measures
A critical question remains: are the transcriptional patterns iden-
tified herein specific for AG in comparison to other metabolic
parameters? As a preliminary step, we applied multidimensional
scaling to the AHBA data, which places each of the900 micro-
array samples in a 2D coordinate space on the basis of their rela-
tion to the first two principle components of the data set. Regions
with high AG were found to cluster independently from regions
with low AG along the y axis (principle coordinate 2) in the result-
ing plot, whereas, for example, high versus low oxygen extrac-
tion fraction (OEF) regions separated along the x axis (principle
coordinate 1; Figure S2A). This result demonstrates that meta-
bolic differences among brain regions are represented in their
transcriptional differences.
To analyze these differences, we used WGCNA (Langfelder
and Horvath, 2008). WGCNA analyzes gene coexpression
graphs, identifies clusters within the graph, and calculates the
first principle component (eigengene) within each cluster. Thus,
WGCNA reduces the dimensionality of a very large data set
(30,000 3 30,000 coexpressed genes) to 30 eigengenes
across 900 brain regions. We found distinct correlations
between AG and AHBA eigengenes (Figure 5). AG most highly
correlated with clusters associated with neurite growth, synaptic
growth, and development (cluster eigengenes A14, A19, and
A30). In contrast, CMRglc correlated best with clusters related
to mitochondria and synaptic transmission (A3, A4, and A26),
which is consistent with the principle that synaptic activity drivesCdemand for ATP (Figure 5 and Table S5). Othermetabolic param-
eters, including CMRO2, CBF, CBV, and OEF, also showed
specific and distinct relationships to the AHBA eigengenes
(Figure S2B).
DISCUSSION
In all life forms, there is a fundamental tradeoff between the effi-
cient production of energy and increases in biomass. Bacteria
evolve according to this tradeoff to occupy niches on the basis
of either high ATP yield or rapid growth (Pfeiffer et al., 2001;
Schuetz et al., 2012). Cancer cells, defined by their rapid, uncon-
trolled proliferation, amplify the latter by shifting glucose
consumption toward biosynthetic reactions; that is, toward AG
(Locasale and Cantley, 2011; Lunt and Vander Heiden, 2011).
Therefore, it is not surprising that the rapidly growing human
child brain is also highly engaged in AG. Furthermore, the most
neotenous regions of the adult brain retain relatively increased
levels of AG. Altogether, these results support the hypothesis
that brain AG has a similar role to that seen in cancer cells;
namely, to support the biosynthesis required for brain growth.
More specifically, we hypothesize that AG supports synaptic
and neurite formation as well as turnover, which most likely per-
sists throughout the lifespan (Goyal and Raichle, 2013; Marder
and Goaillard, 2006).
It is intriguing to speculate about the metabolic mechanisms
by which AG may support brain development and synaptic turn-
over. In astrocytes, AG is an obligatory step in the metabolism of
glutamate released at active synapses (Pellerin and Magistretti,
1994). Some fraction of the resulting lactate may be taken up
by neurons; this process is known as the ‘‘astrocyte-neuron
lactate shuttle’’ (Kasischke et al., 2004). The ultimate fate of
this lactate is uncertain. Much of it may be converted to pyruvateell Metabolism 19, 49–57, January 7, 2014 ª2014 Elsevier Inc. 53
Figure 5. Aerobic Glycolysis Is Associated
with a Distinct Spatiotemporal Transcrip-
tional Profile in Comparison to CMRglc
(A) Genes in the AHBA were clustered with
WGCNA (see the Experimental Procedures). Node
connections represent internodal eigengene cor-
relations. Spatial grouping in the figure represents
gene coexpression. Correlations between each
eigengene and total glucose consumption
(CMRglc) or aerobic glycolysis were assessed.
Node size and color (green, low; red, high) repre-
sent eigengene correlation with either CMRglc
(top) or aerobic glycolysis (bottom). Aerobic
glycolysis is associated with gene clusters sur-
rounding A19. In contrast, CMRglc is associated
gene clusters near A4.
(B) Mean correlations between CMRglc versus AG
and eigengenes representing gene clusters sur-
rounding A4 and A19. According to DAVID gene
ontology analysis (Table S5), A4 and adjacent (A3,
A6, A13, A26, and A29) gene clusters are associ-
ated with mitochondria, Golgi apparatus, synaptic
transmission, and protein transport. In contrast,
gene clusters surrounding A19 (A14, A21, A30,
A31, and A32) are associated with synapses
and dendrites, neuron projection development,
calcium binding, response to glucose, and
‘‘learning.’’ Error bars represent SEM in the cor-
relations for the five or six clusters in each group.
See also Figure S2 and Tables S5 and S6.
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Human Brain Neoteny and Aerobic Glycolysisandmetabolized through oxidative phosphorylation. Lactate has
metabolic signaling functions (Barros, 2013). It also stimulates
gene expression related to long-term memory (Barros, 2013;
Suzuki et al., 2011). Lactate affects the redox state of neurons,
thereby directing glycolytic intermediates toward biosynthetic
pathways as well as increasing neuronal excitability (Cerda´n
et al., 2006; Ido et al., 2004; Mintun et al., 2004). In neurons,
lactatemay spare some glucose from oxidative phosphorylation;
this glucose then may contribute three-carbon fragments to
anabolic pathways used for creating or turning over synapses
(Pavlides et al., 2010; Vaishnavi et al., 2010). Measured AG
may also represent lactate efflux generated by glycolysis or a
glycogen shunt in order to rapidly supply ATP at intensely active
synapses (Shulman et al., 2001). Accordingly, it may not be
coincidental that neuronal bursting plays a role in shaping syn-
aptic connections during development (Katz and Shatz, 1996).
These alternative accounts of AG are not mutually exclusive,
and experimental investigation is needed in order to sort through
the various possibilities.
Interestingly, in the adult brain, the highest levels of resting
state AG are found in the default mode network (DMN), a
constellation of brain regions originally identified as most active
in the absence of attention-demanding, goal-directed task per-
formance (Raichle et al., 2001). More recently, the DMN has
emerged as among the most functionally robust networks in
the brain, as evidenced by its correlated intrinsic activity (Fox
and Raichle, 2007), a property now widely referred to as func-
tional connectivity (Bullmore and Sporns, 2012). The DMN also
constitutes a central hub of structural (axonal) connectivity
(Bullmore and Sporns, 2012; Vaishnavi et al., 2010). An
attractive hypothesis is that the reason these centrally con-
nected regions in the human brain are high in AG is that their54 Cell Metabolism 19, 49–57, January 7, 2014 ª2014 Elsevier Inc.function requires high levels of new synaptic growth and
remodeling.
Similarly, brain AG was previously found to be highest in
regions most vulnerable to amyloid deposition (Vlassenko
et al., 2010). Given the present findings, it is intriguing to consider
the possibility that amyloid deposition is linked to high rates of
synaptic turnover (Bufill et al., 2011; Nikolaev et al., 2009).
Additional studies investigating the evolution of brain AG in
neurodegenerative diseases, as well as neurodevelopmental
abnormalities such as schizophrenia, are warranted.
Theexistenceof topographic geneexpressiondatabases (e.g.,
AHBA and BSS) raises the possibility of using imaging to inform
the significance of gene expression patterns and vice versa.
However, few studies along these lines have been published.
This study is an example of such an analysis resulting in a strong
correspondence between the regional variance of an imaging
parameter (in this case, AG) and specific gene expression.
Our study has several limitations. The meta-analysis of human
brain AG (Figure 2) is based on incomplete data obtained with
different methods across studies and age groups. These results
should be confirmed. Unfortunately, obtaining additional quanti-
tative metabolic data during the first two decades of life with PET
in normal humans cannot be justified because of radiation safety
concerns. Efforts to obtain data of this type in developing
nonhuman primates should be considered. Another caveat is
that gene expression levels may only modestly correlate with
protein and enzyme levels because of posttranscriptional modi-
fications. Finally, our results do not address causation. Hence,
additional studies will be needed to explore whether AG is
induced by or required for the biosynthetic requirements of
synapse and neurite formation. Thus, our analyses link AG to
synaptic and neurite growth and formation but do not elucidate
Cell Metabolism
Human Brain Neoteny and Aerobic Glycolysisthe specific mechanisms by which this occurs. Possible func-
tions of AG include providing carbon-enriched substrates,
providing ATP and NAD+ rapidly, and reducing reactive oxygen
species. All of these functions are believed to be important in
proliferating cells, but some may be relatively more important
in the brain.
In summary, AG is potentiated during childhood, persists in
neotenous adult brain regions, and spatially correlates with
gene expression related to synapse formation and neurite
growth. These observations suggest that a primary role of AG
is as a biosynthetic support of the aforementioned cellular
processes. Accordingly, in vivo measurement of AG may be
informative regarding synaptic growth and turnover in health
and disease. Thus, impaired brain AG may represent a useful
biomarker of pathology in neurodegenerative diseases.
EXPERIMENTAL PROCEDURES
Meta-Analysis of Brain Metabolism across the Lifespan
The meta-analysis reported in Figure 2 was based on in-depth review of the
literature with the use of PubMed, Google Scholar, and reference lists in
several papers identifying studies that measured glucose or oxygen meta-
bolism over the whole brain or cerebral cortex. We included measurements
obtained with either the (modified) Kety-Schmidt method or PET imaging. In
some cases, reported values were extracted from charts and/or tables. Meta-
bolic data were expressed as glucose mmol/100 g/min and oxygen ml/100 g/
min. Oxygen metabolism was also expressed in terms of ‘‘expected’’ glucose
consumption that would be required to fully account for oxygen consumed,
assuming a 6:1 stoichiometric relationship between oxygen and glucose con-
sumption. Loess curves were fit to the data with the built-in R script loessR.
Data were also normalized to average adult values in order to compare oxygen
and glucose consumption to cerebral blood flow across the human lifespan.
Finally, the OGI was computed as the molar ratio of oxygen consumption to
glucose consumption: OGI = CMRO2 (ml/100 g/min)3 44.7 mmol/ml / CMRglc
(mmol/100 g/min).
Brain PETData Analysis andRegional Alignment to GeneExpression
Data
The remaining analyses comparing gene expression to PET imaging data were
based on regional measurements of CMRglc, CMRO2, cerebral blood flow
(CBF), and cerebral blood volume (CBV) acquired in our laboratory in 33 normal
young adults. A prior report discusses the regional dependence of these
parameters as well as AG calculated via the glycolytic index—a measure of
glucose consumption in excess of that expected on the basis of CMRO2.
AG and the OGI are nearly perfectly inversely correlated (r = 0.98) (Vaishnavi
et al., 2010). The regional PET data for each metabolic parameter, including
AG, were aligned to individual regions acquired in the AHBA via Montreal
Neurological Institute coordinates, which were provided by the Allen Brain
Institute and via atlas registration of the PET data. The regional PET data
were aligned to the BSS data via regional, and Brodmann area measurements
provided in the original report of this data (Vaishnavi et al., 2010). Furthermore,
we compared these measurements to a similar set of PET measurements in
FreeSurfer-derived regions matched to the BSS regional nomenclature and
found only slight differences.
Preprocessing of Brain Gene Expression Data
Methods describing production and initial analysis of adult human brain aero-
bic glycolysis, adult human brain gene expression, and human brain gene
expression across the lifespan have been previously published (ABHA and
BSS) (Hawrylycz et al., 2012; Kang et al., 2011; Vaishnavi et al., 2010). Donor
brains with postmortem intervals > 24 hr or with > 25% of microarray samples
with an RNA integrity index (RIN) less than 7.5 were excluded in order to maxi-
mize the integrity of our analysis. Hence, data from only one of the AHBA
donors was used, given that only this brain met our stringent RNA integrity
and postmortem interval criteria. The AHBA data were corrected for batchCeffects and normalized to the 75%quantile as previously described (Hawrylycz
et al., 2012). BSS data were also quantile normalized.
Calculation of Regional Transcriptional Neoteny
The regional neoteny index was calculated as the number of genes (effectively,
the percentage of genes) demonstrating significant neoteny on the basis of
themethod of Somel et al. (2009). A genewas defined as neotenous in a partic-
ular region if its expression exhibited prolonged, delayed, or increased expres-
sion in that region relative to its expression in the cerebellum (p < 0.01 cutoff).
Thus, by definition, there are zero neotenous genes in the cerebellum (CBC) in
comparison to itself. The cerebellum was used as the ‘‘reference species’’ in
these calculations, given that the cerebellum shows the lowest AG among
all brain regions assessed in the BSS. Median age shift was also used as an
alternative measure of regional transcriptional neoteny and was calculated
with the method of Somel et al. (2009). Then, the regional neoteny index and
median age shift calculations were compared to AG with region-wise Pearson
correlation.
Regional Comparative Analysis of the Brain PET and Gene
Expression Data
Genes in common between the AHBA and BSS (n = 17,205) were rank ordered
according to their correlation with AG. Similarity among rank-ordered gene
lists was computed with OrderedListR (Lottaz et al., 2006). We searched for
genes consistently found in the top 1,000 out of the 17,205 in each of the
AHBA and 5 BSS age- and RIN-matched adult brains; this search identified
the 116 genes described in the Results. To evaluate the significance of this
finding, we performed the same analysis after repeatedly shuffling the AG
values among the 16 BSS regions in order to measure the percentage of in-
stances that produced an equivalent number of genes in comparison to the
actual AG values (AHBAwas excluded from this permutation analysis because
of the difficulty in relating shuffled BSS AG values to the AHBA regions). The
results of the permutation analysis are reported in Figure S1. The 116 AG-
associated genes were analyzed with three gene ontology methods, including
GeneMANIA (Warde-Farley et al., 2010), DAVID (Huang da et al., 2009), and
userListEnrichmentR (Miller et al., 2011) (Table 1, see also Tables S3 and S4).
Multidimensional scaling (MDS) was performed with cmdscaleR, a built-in
function in the open-source R statistical programming language (version
2.13.2) on the AHBA data across regions. The first two principal components
derived from the MDS analysis are shown in Figure S2A. PET-derived meta-
bolic measurements are superimposed on the MDS results. Regions with
high (>1 SD above the mean) or low (>1 SD below the mean) metabolic values
are color coded (red versus blue, respectively).
WGCNAwas performedwith theWGCNA (version 1.18-2) R package. Meta-
bolic parameters were compared to each cluster of genes in the AHBA with
Pearson correlation between the spatial pattern of metabolism with each clus-
ter eigengene (Langfelder and Horvath, 2008). Clusters of genes in the BSS
were compared to each metabolic parameter by calculating the correlation
of gene significance for metabolism with its membership in each cluster.
Gene ontology analysis of each cluster was performed with DAVID (Huang
da et al., 2009). Gephi was used to construct Fruchterman-Reingold represen-
tations of the AHBA network that were sized and colored according to their
correlation with aerobic glycolysis and CMRglc.
The R scripts and preprocessed data used by these scripts are available for
free download at ftp://imaging.wustl.edu/pub/goyal/.
SUPPLEMENTAL INFORMATION
Supplemental Information contains Supplemental Experimental Procedures,
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